Bay Street News, March, 2024

FORT LAUDERDALE, FL, March 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the [...]

STAMFORD, Conn., March 01, 2024 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (NYSE: EGLE) (“Eagle” or the “Company”), one of […]

VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) — Discovery Lithium Inc. (CSE: DCLI) (OTC: DCLIF) (FRA: Q3Q0) (WKN: A3EFKA) […]

RESTON, Va., March 01, 2024 (GLOBE NEWSWIRE) — Comscore, Inc. (NASDAQ: SCOR) and TEGNA Inc. (NYSE: TGNA) today announced they […]

Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and […]

JUPITER, Fla. , March 01, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global […]

– Topline data from the Phase 1 portion of Phase 1/2a trial of IMM-1-104 expected in March 2024 – – […]

HIGH POINT, N.C., March 01, 2024 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused […]

CUPERTINO, CA, March 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will […]

SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage […]